Clinical detection of BCR-ABL fusion by in situ hybridization in chronic myelogenous leukemia

A. Amiel*, S. Yarkoni, M. Fejgin, E. Gaber, A. Nagler, Y. Manor, M. Lishner

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

26 Scopus citations

Abstract

We describe the use of the fluorescence in situ hybridization (FISH) technique to detect residual Philadelphia chromosome-positive (Ph+) cells in a patient with blastic phase chronic myelogenous leukemia (CML) after aggressive cytoreductive treatment. The analysis was made in interphase nuclei because of the very small number of recognizable metaphases in leukemic patients. FISH was a reliable tool for the detection of chromosome translocations in interphase nuclei as compared with conventional cytogenetic and polymerase chain reaction (PCR) techniques.

Original languageEnglish
Pages (from-to)32-34
Number of pages3
JournalCancer Genetics and Cytogenetics
Volume65
Issue number1
DOIs
StatePublished - Jan 1993
Externally publishedYes

Fingerprint

Dive into the research topics of 'Clinical detection of BCR-ABL fusion by in situ hybridization in chronic myelogenous leukemia'. Together they form a unique fingerprint.

Cite this